{"product_id":"malignant-benign-tumor-prophylaxis-cancer-abnobaviscum-aceris-2-mg-ampoules","title":"Malignant, benign tumor, prophylaxis, cancer, ABNOBAVISCUM Aceris 2 mg ampoules","description":"\u003ch1 content=\"ABNOBAVISCUM-Aceris-2-mg-Ampullen\" itemprop=\"name\"\u003e\u003cspan\u003eABNOBAVISCUM Aceris 2 mg ampoules, Malignant, benign tumor, prophylaxis, cancer\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp\u003e\u003cspan\u003eFor extended treatment of tumor diseases\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 class=\"a-h4 u-no-margin u-font-weight--bold\"\u003e\u003cspan\u003eactive Malignant, benign tumor, prophylaxis, cancer, ABNOBAVISCUM Aceris 2 mg ampoules ingredients\u003c\/span\u003e\u003c\/h3\u003e\n\u003cdiv class=\"o-ProductAdditionalInformation u-clearfix\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003e0.1 ml maple mistletoe extract (1:50);\u003cspan\u003e \u003c\/span\u003eExtraction agents: sodium monohydrogen phosphate dihydrate, ascorbic acid, water for injections\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"a-h4 u-no-margin u-font-weight--bold\"\u003e\u003cspan\u003eexcipients\u003c\/span\u003e\u003c\/h3\u003e\n\u003cdiv class=\"o-ProductAdditionalInformation u-clearfix\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003ewater for injections\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eascorbic acid\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003edisodium hydrogen phosphate-2-water\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eActive ingredient:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eEach ampoule contains 0.1 ml extract from fresh maple mistletoe.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eWhat is abnoba VISCUM and what is it used for?\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eabnobaVISCUM is an anthroposophic medicinal product for the extended treatment of tumor diseases.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003e\u003cspan\u003eAreas of Malignant, benign tumor, prophylaxis, cancer, ABNOBAVISCUM Aceris 2 mg ampoules application:\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cbr\u003e\u003cspan\u003eAccording to anthroposophical knowledge of man and nature, abnoba-VISCUM is used to stimulate the formative and integrative forces in adults to dissolve and reintegrate independent growth processes, e.g\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003ein malignant tumor diseases, also with accompanying disorders of the blood-forming organs\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ein benign tumor diseases\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eto prevent recurrence (recurrence prophylaxis) after tumor surgery\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan\u003ein the early stages of certain cancers (defined precancerous lesions).\u003c\/span\u003e\u003cbr\u003e \u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eHow is abnobaViSCUM to be used?\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch4\u003e\u003cstrong\u003e\u003cspan\u003eType of Malignant, benign tumor, prophylaxis, cancer, ABNOBAVISCUM Aceris 2 mg ampoules application: If\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003e\u003cbr\u003e\u003cspan\u003epossible, the subcutaneous injection should be carried out in the vicinity of the tumor or metastases, otherwise in constantly changing parts of the body (different parts in the abdominal area, possibly thigh or upper arm).\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDo not inject into inflamed skin areas or radiation fields.\u003cspan\u003e \u003c\/span\u003eStrictly subcutaneous injection technique should be used.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAs a precaution, it is recommended not to draw up abnobaVISCUM with other medicines in one syringe.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAfter cleaning the puncture site (e.g. by rubbing with 70% alcohol), fold the skin and insert the injection needle at an angle.\u003cspan\u003e \u003c\/span\u003eSlightly withdraw the syringe plunger.\u003cspan\u003e \u003c\/span\u003eIf blood appears, a blood vessel has been hit.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn this case, repeat the injection at a different site.\u003cspan\u003e \u003c\/span\u003eIf no blood appears, inject slowly, then withdraw the needle and briefly press the puncture site with a swab.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn any case, it is recommended to learn the injection technique from a person experienced in it.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAmpoules should be injected immediately after opening.\u003cspan\u003e \u003c\/span\u003eOpened ampoules must not be used for a later injection.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eOnly the potency levels D 10, D 20 and D 30:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eFor the potency levels D 10, D 20 and D 30, the required dose can be mixed into an infusion solution (physiological saline solution or 5% glucose solution) and slowly infused intravenously in special cases.\u003cspan\u003e \u003c\/span\u003eThe infusion time should be at least 90 minutes for 250 ml.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\n\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eDosage Malignant, benign tumor, prophylaxis, cancer, ABNOBAVISCUM Aceris 2 mg ampoules and frequency of use\u003c\/span\u003e\u003c\/strong\u003e\n\u003c\/h2\u003e\n\u003cp\u003e\u003cbr\u003e\u003cspan\u003edepend on the respective physical condition and are determined individually by your doctor.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eDosage and frequency of use:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eInitiation phase:\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eUnless otherwise stated, the dosage is always 1 ml of the injection solution of the specified strength or potency level.\u003cspan\u003e \u003c\/span\u003eYou should start treatment with the 0.02 mg strength three times a week (for the 0.02 mg, 0.2 mg, 2 mg, 20 mg and potency level D 6 strengths) and then cautiously continue with the next higher doses until until you reach the optimal dose.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe dosage is always individual according to the doctor's instructions and depends on your reaction situation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe potency levels D 10 – D 30 are to be used according to the individual indication.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe optimal concentration or dose must be determined individually.\u003cspan\u003e \u003c\/span\u003eAccording to the current state of knowledge, the following reactions, which can occur individually or in combination, must be observed:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ea) Change in subjective well-being:\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eimprovement in general well-being (increase in appetite and weight, normalization of sleep, sensitivity to warmth and performance) and mental well-being (brightening of mood, increase in courage and initiative) as well as alleviation of pain show you that you dose in the effective range.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAny fatigue, shivering, general feeling of illness, headaches and brief dizziness that may occur on the day of the injection are not signs of intolerance, but indicate an effective dosage that may already be too high.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIf these symptoms have not disappeared by the following day or are above a tolerable level, the strength or dose should be reduced.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eb) Temperature response:\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eA temperature response in the form of an above-average increase in body temperature a few hours after injection, in the form of a restoration of the physiological morning\/evening difference of at least 0.5°C, or an increase in the mean temperature level during treatment.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn the case of tumor fever, on the other hand, low concentrations are used to normalize and rhythmize the core temperature.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ec) Immunological reaction:\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eYour doctor can determine a positive reaction of your immune system through laboratory tests of your blood.\u003cspan\u003e \u003c\/span\u003eThis can be demonstrated, for example, by an increase in certain white blood cells (lymphocytes and eosinophils) in the blood and by an improvement in the cellular immune status in the recall antigen test or when determining the lymphocyte subpopulations.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003ed) Local inflammatory reaction:\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eA local reaction occurs at the injection site.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis should not be larger than 5 cm in diameter.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eMaintenance phase:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eUnless otherwise prescribed:\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eThe individual dose can be as low as 0.02 mg.\u003cspan\u003e \u003c\/span\u003eOtherwise, gradually increase the concentration to strengths of 0.2 mg, 2 mg and 20 mg, each with 2-3 injections per week.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eSince violent reactions can occur when changing from one strength to the next, only half an ampoule of the next higher concentration should be injected at first.\u003cspan\u003e \u003c\/span\u003eIf too strong reactions occur even with the strength of 0.02 mg, you should switch to the potency level D6.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIf the reactions are too strong here too, you should only use a third of the ampoule, switch to D10 or to abnobaVISCUM from another host tree.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIn the cases mentioned above, the use of 0.5 ml or 0.3 ml abnobaVISCUM using a graduated 1 ml syringe is recommended.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eDuring radiotherapy, chemotherapy or hormone therapy or after an operation, your individual reaction situation may change, making it necessary to adjust the dose.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe treatment is continued with the optimal individual concentration or dose determined in this way.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eTo avoid habituation effects, rhythmic application is recommended in the form of:\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003ealternation with lower concentrations or doses in the form of increasing and possibly also decreasing dosages or repeating the rhythm of the injection intervals.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe dosage should be reviewed at intervals of 3-6 months based on patient response and tumor behavior.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003e\u003cspan\u003eMalignant, benign tumor, prophylaxis, cancer, ABNOBAVISCUM Aceris 2 mg ampoules Dosage in the case of impaired renal function:\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cbr\u003e\u003cspan\u003eThere is insufficient data for specific dosage recommendations in the case of impaired renal function.\u003cspan\u003e \u003c\/span\u003eGeneral experience has so far shown no need for dose adjustment.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eDuration of use:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eIn principle, the duration of treatment is not limited.\u003cspan\u003e \u003c\/span\u003eIt is determined by your doctor and depends on the respective risk of a tumor recurrence (recurrence of a similar tumor after previous treatment) and on your individual condition or findings.\u003cspan\u003e \u003c\/span\u003eIt should be several years, with breaks of increasing length usually being taken.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eApplication errors:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003eIf you have used a larger amount of abnobaVISCUM than you should, reactions such as those described under side effects can occur.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe next injection should then only be given after these symptoms have subsided and at a reduced dosage.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIf you have forgotten to use abnobaVISCUM, follow your normal therapy plan for the further injections.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIf you stop using abnobaVISCUM, you have to start again with the low starting dose when you start the therapy again.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003e\u003cspan\u003eMalignant, benign tumor, prophylaxis, cancer, ABNOBAVISCUM Aceris 2 mg ampoules. What abnobaVISCUM contains:\u003c\/span\u003e\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cbr\u003e\u003cspan\u003eThe active ingredient is 0.1 ml extract from fresh maple mistletoe (plant to extract = 1:50).\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eExtraction agent:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003esodium monohydrogen phosphate dihydrate, ascorbic acid, water for injections (2.03:0.34:97.63)\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eExcipients:\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\u003cspan\u003edisodium phosphate dihydrate, disodium phosphate monohydrate, ascorbic acid, water for injections\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"ABNOBA Ltd","offers":[{"title":"8 pcs","offer_id":44717160202557,"sku":"05961862","price":248.61,"currency_code":"GBP","in_stock":true},{"title":"21 pcs","offer_id":44717160235325,"sku":"05961879","price":667.03,"currency_code":"GBP","in_stock":true},{"title":"48 pcs","offer_id":44717160268093,"sku":"05961885","price":1590.42,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0637\/3952\/7353\/files\/malignant-benign-tumor-prophylaxis-cancer-abnobaviscum-aceris-2-mg-ampoules-uk-1.jpg?v=1716147500","url":"https:\/\/eliveragroup.co.uk\/products\/malignant-benign-tumor-prophylaxis-cancer-abnobaviscum-aceris-2-mg-ampoules","provider":"ELIVERA UK","version":"1.0","type":"link"}